Cargando…

Development and Validation of a Predictive Scoring System for Colorectal Cancer Patients With Liver Metastasis: A Population-Based Study

Liver metastasis in colorectal cancer (CRC) is common and has an unfavorable prognosis. This study aimed to establish a functional nomogram model to predict overall survival (OS) and cancer-specific survival (CSS) in patients with colorectal cancer liver metastasis (CRCLM). A total of 9,736 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Yinghao, Ke, Songqing, Deng, Shenghe, Yan, Lizhao, Gu, Junnan, Mao, Fuwei, Xue, Yifan, Zheng, Changmin, Cai, Wentai, Liu, Hongli, Li, Han, Shang, Fumei, Sun, Zhuolun, Wu, Ke, Zhao, Ning, Cai, Kailin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671306/
https://www.ncbi.nlm.nih.gov/pubmed/34926243
http://dx.doi.org/10.3389/fonc.2021.719638
_version_ 1784615120115073024
author Cao, Yinghao
Ke, Songqing
Deng, Shenghe
Yan, Lizhao
Gu, Junnan
Mao, Fuwei
Xue, Yifan
Zheng, Changmin
Cai, Wentai
Liu, Hongli
Li, Han
Shang, Fumei
Sun, Zhuolun
Wu, Ke
Zhao, Ning
Cai, Kailin
author_facet Cao, Yinghao
Ke, Songqing
Deng, Shenghe
Yan, Lizhao
Gu, Junnan
Mao, Fuwei
Xue, Yifan
Zheng, Changmin
Cai, Wentai
Liu, Hongli
Li, Han
Shang, Fumei
Sun, Zhuolun
Wu, Ke
Zhao, Ning
Cai, Kailin
author_sort Cao, Yinghao
collection PubMed
description Liver metastasis in colorectal cancer (CRC) is common and has an unfavorable prognosis. This study aimed to establish a functional nomogram model to predict overall survival (OS) and cancer-specific survival (CSS) in patients with colorectal cancer liver metastasis (CRCLM). A total of 9,736 patients with CRCLM from 2010 to 2016 were randomly assigned to training, internal validation, and external validation cohorts. Univariate and multivariate Cox analyses were performed to identify independent clinicopathologic predictive factors, and a nomogram was constructed to predict CSS and OS. Multivariate analysis demonstrated age, tumor location, differentiation, gender, TNM stage, chemotherapy, number of sampled lymph nodes, number of positive lymph nodes, tumor size, and metastatic surgery as independent predictors for CRCLM. A nomogram incorporating the 10 predictors was constructed. The nomogram showed favorable sensitivity at predicting 1-, 3-, and 5-year OS, with area under the receiver operating characteristic curve (AUROC) values of 0.816, 0.782, and 0.787 in the training cohort; 0.827, 0.769, and 0.774 in the internal validation cohort; and 0.819, 0.745, and 0.767 in the external validation cohort, respectively. For CSS, the values were 0.825, 0.771, and 0.772 in the training cohort; 0.828, 0.753, and 0.758 in the internal validation cohort; and 0.828, 0.737, and 0.772 in the external validation cohort, respectively. Calibration curves and ROC curves revealed that using our models to predict the OS and CSS would add more benefit than other single methods. In summary, the novel nomogram based on significant clinicopathological characteristics can be conveniently used to facilitate the postoperative individualized prediction of OS and CSS in CRCLM patients.
format Online
Article
Text
id pubmed-8671306
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86713062021-12-16 Development and Validation of a Predictive Scoring System for Colorectal Cancer Patients With Liver Metastasis: A Population-Based Study Cao, Yinghao Ke, Songqing Deng, Shenghe Yan, Lizhao Gu, Junnan Mao, Fuwei Xue, Yifan Zheng, Changmin Cai, Wentai Liu, Hongli Li, Han Shang, Fumei Sun, Zhuolun Wu, Ke Zhao, Ning Cai, Kailin Front Oncol Oncology Liver metastasis in colorectal cancer (CRC) is common and has an unfavorable prognosis. This study aimed to establish a functional nomogram model to predict overall survival (OS) and cancer-specific survival (CSS) in patients with colorectal cancer liver metastasis (CRCLM). A total of 9,736 patients with CRCLM from 2010 to 2016 were randomly assigned to training, internal validation, and external validation cohorts. Univariate and multivariate Cox analyses were performed to identify independent clinicopathologic predictive factors, and a nomogram was constructed to predict CSS and OS. Multivariate analysis demonstrated age, tumor location, differentiation, gender, TNM stage, chemotherapy, number of sampled lymph nodes, number of positive lymph nodes, tumor size, and metastatic surgery as independent predictors for CRCLM. A nomogram incorporating the 10 predictors was constructed. The nomogram showed favorable sensitivity at predicting 1-, 3-, and 5-year OS, with area under the receiver operating characteristic curve (AUROC) values of 0.816, 0.782, and 0.787 in the training cohort; 0.827, 0.769, and 0.774 in the internal validation cohort; and 0.819, 0.745, and 0.767 in the external validation cohort, respectively. For CSS, the values were 0.825, 0.771, and 0.772 in the training cohort; 0.828, 0.753, and 0.758 in the internal validation cohort; and 0.828, 0.737, and 0.772 in the external validation cohort, respectively. Calibration curves and ROC curves revealed that using our models to predict the OS and CSS would add more benefit than other single methods. In summary, the novel nomogram based on significant clinicopathological characteristics can be conveniently used to facilitate the postoperative individualized prediction of OS and CSS in CRCLM patients. Frontiers Media S.A. 2021-12-01 /pmc/articles/PMC8671306/ /pubmed/34926243 http://dx.doi.org/10.3389/fonc.2021.719638 Text en Copyright © 2021 Cao, Ke, Deng, Yan, Gu, Mao, Xue, Zheng, Cai, Liu, Li, Shang, Sun, Wu, Zhao and Cai https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Cao, Yinghao
Ke, Songqing
Deng, Shenghe
Yan, Lizhao
Gu, Junnan
Mao, Fuwei
Xue, Yifan
Zheng, Changmin
Cai, Wentai
Liu, Hongli
Li, Han
Shang, Fumei
Sun, Zhuolun
Wu, Ke
Zhao, Ning
Cai, Kailin
Development and Validation of a Predictive Scoring System for Colorectal Cancer Patients With Liver Metastasis: A Population-Based Study
title Development and Validation of a Predictive Scoring System for Colorectal Cancer Patients With Liver Metastasis: A Population-Based Study
title_full Development and Validation of a Predictive Scoring System for Colorectal Cancer Patients With Liver Metastasis: A Population-Based Study
title_fullStr Development and Validation of a Predictive Scoring System for Colorectal Cancer Patients With Liver Metastasis: A Population-Based Study
title_full_unstemmed Development and Validation of a Predictive Scoring System for Colorectal Cancer Patients With Liver Metastasis: A Population-Based Study
title_short Development and Validation of a Predictive Scoring System for Colorectal Cancer Patients With Liver Metastasis: A Population-Based Study
title_sort development and validation of a predictive scoring system for colorectal cancer patients with liver metastasis: a population-based study
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671306/
https://www.ncbi.nlm.nih.gov/pubmed/34926243
http://dx.doi.org/10.3389/fonc.2021.719638
work_keys_str_mv AT caoyinghao developmentandvalidationofapredictivescoringsystemforcolorectalcancerpatientswithlivermetastasisapopulationbasedstudy
AT kesongqing developmentandvalidationofapredictivescoringsystemforcolorectalcancerpatientswithlivermetastasisapopulationbasedstudy
AT dengshenghe developmentandvalidationofapredictivescoringsystemforcolorectalcancerpatientswithlivermetastasisapopulationbasedstudy
AT yanlizhao developmentandvalidationofapredictivescoringsystemforcolorectalcancerpatientswithlivermetastasisapopulationbasedstudy
AT gujunnan developmentandvalidationofapredictivescoringsystemforcolorectalcancerpatientswithlivermetastasisapopulationbasedstudy
AT maofuwei developmentandvalidationofapredictivescoringsystemforcolorectalcancerpatientswithlivermetastasisapopulationbasedstudy
AT xueyifan developmentandvalidationofapredictivescoringsystemforcolorectalcancerpatientswithlivermetastasisapopulationbasedstudy
AT zhengchangmin developmentandvalidationofapredictivescoringsystemforcolorectalcancerpatientswithlivermetastasisapopulationbasedstudy
AT caiwentai developmentandvalidationofapredictivescoringsystemforcolorectalcancerpatientswithlivermetastasisapopulationbasedstudy
AT liuhongli developmentandvalidationofapredictivescoringsystemforcolorectalcancerpatientswithlivermetastasisapopulationbasedstudy
AT lihan developmentandvalidationofapredictivescoringsystemforcolorectalcancerpatientswithlivermetastasisapopulationbasedstudy
AT shangfumei developmentandvalidationofapredictivescoringsystemforcolorectalcancerpatientswithlivermetastasisapopulationbasedstudy
AT sunzhuolun developmentandvalidationofapredictivescoringsystemforcolorectalcancerpatientswithlivermetastasisapopulationbasedstudy
AT wuke developmentandvalidationofapredictivescoringsystemforcolorectalcancerpatientswithlivermetastasisapopulationbasedstudy
AT zhaoning developmentandvalidationofapredictivescoringsystemforcolorectalcancerpatientswithlivermetastasisapopulationbasedstudy
AT caikailin developmentandvalidationofapredictivescoringsystemforcolorectalcancerpatientswithlivermetastasisapopulationbasedstudy